2SEVENTY BIO INC (TSVT)

US9013841070 - Common Stock

4.5  +0.24 (+5.63%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
100.39M91.50M54.50M248.10M44.30M
Cost Of Goods
16.92M16.60M2.50M5.40M3.00M
Gross Profit
83.47M74.90M52.00M242.70M41.30M
Operating Expenses
300.41M328.40M355.90M380.90M382.00M
Research and Development
230.76M248.70M261.90M296.50M297.60M
Selling, General, and Administrative Expenses
69.41M79.50M93.50M90.90M81.60M
Operating Income
-216.94M-253.50M-303.80M-138.20M-340.70M
Interest Income/Expense
12.41M2.90M100.00K0.000.00
Other Income/Expense
7.63M6.10M21.60M18.10M20.10M
Non Recurring Items
-20.67M-9.60M-10.10MN/AN/A
Income Before Taxes
-217.57M-254.20M-292.20M-120.10M-320.60M
Income Tax
N/A0.000.000.000.00
Net Income
-217.57M-254.20M-292.20M-120.10M-320.60M
EBITDA
-206.65M-241.97M-287.45M-125.01M-328.11M
 
Per Share Data
EPS Diluted Total Ops
-4.42-7.13-12.44-5.14-13.72
Non GAAP EPS
-4.02-7.58N/AN/AN/A
 
Statistics
Gross Profit Margin
83.15%81.86%95.41%97.82%93.23%
Profit Margin
-216.73%-277.81%-536.15%-48.41%-723.70%
Operating Profit Margin
-216.10%-277.05%-557.43%-55.70%-769.07%

All data in USD

Charts